(Q52105169)

22 April 2018

title

Neuropsychiatric effects of chemotherapeutic agents for cancer. (English)

1 reference

22 April 2018

1 reference

Peterson LG

1

1 reference

22 April 2018

Popkin MK

series ordinal

2

1 reference

22 April 2018

publication date

1 February 1980

1 reference

22 April 2018

published in

Psychosomatics

1 reference

22 April 2018

volume

21

1 reference

22 April 2018

issue

2

1 reference

22 April 2018

page(s)

141-153

1 reference

22 April 2018

Psychosomatic aspects of the cancer problem

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Preliminary studies in animals concerning the relationship between the nervous system and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Personality as factor in the pathogenesis of cancer: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Behaviorally conditioned immunosuppression: replication of a recent study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Psychophysiological complementarity in malignancies: past work and future vistas

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

The informational impact of cancer on the structure of the human personality

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Clues to the psychological management of patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Acute psychiatric problems and the use of psychotropic medications in the treatment of the cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Psychological considerations in the care of patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

THE DEVELOPMENT OF EMOTIONAL COMPLICATIONS IN THE PATIENT WITH CANCER.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

The existential plight in cancer: significance of the first 100 days

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Psychological problems in terminal cancer management

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Psychological impact of cancer and its therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Psychiatric symptoms associated with L-asparaginase administration

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Brain damage after intrathecal methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Encephalopathy in acute leukaemia associated with methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Severe cerebral toxicity after intravenous nitrogen mustard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Acute adverse reactions to prednisone in relation to dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Controlled study of CCNU and radiation therapy in malignant astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Intracerebral calcifications appearing during the course of acute lymphocytic leukemia treated with methotrexate and X-rays

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Progressive multifocal leukoencephalopathy: a complication of immunosuppressive treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Histological effects of 6-mercaptopurine on the fetal rat central nervous system: A light-microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Meningitic Reactions after Azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Letter: Treatment of C.N.S. involvement in systemic lupus erythematosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Floxuridine and its influence on postnatal cerebellar development

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Effect of the antiviral drug, cytosine arabinoside, on the developing nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Taratogenic effects of the pyrimidine analogues 5-iododeoxyuridine and cytosine arabinoside in late fetal mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Treatment of central nervous system leukemia with intrathecal cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Intrathecal arabinosyl cytosine in meningeal leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Vincristine neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

A comparative study of the action of actinomycin D and actinomycinic ACID on the central nervous system when injected into the cerebrospinal fluid of higher animals

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Metabolic and toxic effects of mithramycin during tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Clinical study with bleomycin: tolerance to twice weekly dosage.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Results of a clinical trial with intermittent doses of adriamycin in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Toxicity of L-asparaginase in children with advanced leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Electroencephalogram Changes Secondary to Asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

1 reference

7 January 2021

Toxicity of E. coli L-asparaginase in man

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Dysmetabolic and Neurological Complications in Leukemic Patients Treated with L-Asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

A Summary of the Clinical Status of Asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Mitotane Use in Inoperable Adrenal Cortical Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Irradiation, methotrexate toxicity, and the treatment of meningeal leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Serum folic acid and B12 in 272 psychiatric in-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

Clinical experience with L-asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2880%2973711-8

7 January 2021

10.1016/S0033-3182(80)73711-8

Identifiers

DOI

1 reference

22 April 2018

1 reference

22 April 2018